CARL earnings: next report 2026-08-27, real EPS beat/miss history, analyst consensus Buy, P/E -4.52. Updated 2026-07-23.
Carlsmed (CARL) Research Hub
Carlsmed (CARL) trades on NASDAQ, US in the Healthcare (Medical - Devices) sector. As of 2026-09-11, shares last closed at 14.73 USD (-1.73%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -4.52, market cap 0.30B. This hub links to the full technical, earnings and options research available for CARL.
Last updated 2026-09-11 · Source: FMP end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Medical - Devices) |
|---|---|
| Exchange | NASDAQ, US |
| Last close | 14.73 USD (-1.73%) |
| 52-week range | 9.5 USD – 17.23 USD |
| Trend regime | Range |
| 14-day RSI | 57.6 (Bullish) |
| Trailing P/E | -4.52 |
| Market cap | 0.30B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-27 |
Available research for CARL
Covered Call on CARL: how it works, illustrative setup around the real 14.73 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on CARL: how it works, illustrative setup around the real 14.73 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on CARL: how it works, illustrative setup around the real 14.73 USD price, max profit/loss, breakeven and when to use it. Educational.
CARL technical analysis: range, last 14.73 USD, RSI 57.6, 52w range 9.5 USD–17.23 USD, real support/resistance. Updated 2026-09-11.
Frequently asked questions
What sector is CARL in?
Carlsmed (CARL) is classified under Healthcare (Medical - Devices), listed on NASDAQ, US.
Is CARL in an uptrend or downtrend?
As of 2026-09-11, CARL is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is CARL's trailing P/E ratio?
CARL's trailing P/E is -4.52, with a market cap of 0.30B. See the earnings research page for full valuation detail.
When does CARL next report earnings?
CARL is next scheduled to report earnings on 2026-08-27, with a consensus EPS estimate of -0.32 USD.